Literature DB >> 17160917

Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study.

George Bray, Edward Gregg, Steven Haffner, Xavier F Pi-Sunyer, Lynne E WagenKnecht, Michael Walkup, Rena Wing.   

Abstract

OBJECTIVE: The Look AHEAD (Action for Health in Diabetes) study is a 16-centre randomised clinical trial in overweight and obese individuals with type 2 diabetes, designed to evaluate the long-term effects (up to 11.5 years) of intensive weight loss intervention on the time to incidence of major cardiovascular events. RESEARCH DESIGN AND METHODS: Eligibility requirements are diagnosis of type 2 diabetes (determined by self-report and verification) in individuals aged 4574 years and body mass index (BMI) > 25 kg/m2 (> 27 kg/m2 if currently taking insulin). The intensive lifestyle intervention is designed to achieve and maintain weight loss through decreased caloric intake and increased physical activity. The study is designed to provide 90% probability of detecting an 18% difference in major cardiovascular disease event rates in patients randomised to the intensive lifestyle intervention compared to the control group receiving standard diabetes support and education.
RESULTS: The 5,145 participants who were randomised between 2001 and 2004 were 63.3% white, 15.6% African-American, 13.2% Hispanic, 5.0% American Indian and 1.0% Asian-American, which closely paralleled the ethnic distribution of diabetes in the National Health and Nutrition Examination Survey (NHANES) 1999-2000 survey. Their average age at entry was 59+/-6.8 years (mean+/-SD), and 60% were women. There were 31.5% between 4555 years of age, 51.5% were 5665, and 17.0% were 6676 years of age. Some 15.4% of participants were taking insulin at the time of randomisation and 14.0% had a history of cardiovascular disease. More men (21.3%) than women (9.2%) had a history of cardiovascular disease. Few participants (4.4%) were current cigarette smokers, compared to 16.2% in the NHANES 1999-2000 survey. Furthermore, 65.0% of participants had a first-degree relative with diabetes. Overall, BMI averaged 36+/-5.9 kg/m2 at baseline, with 83.6% of the men and 86.1% of women having a BMI > 30 kg/m2 and 17.9% of men and 25.4% of women having a BMI > 40 kg/m2.
CONCLUSIONS: The Look AHEAD study has successfully randomised a large cohort of participants who have type 2 diabetes with a wide distribution of age, obesity, ethnicity and racial background and will examine the effects of lifestyle intervention on the incidence of major cardiovascular events.

Entities:  

Mesh:

Year:  2006        PMID: 17160917      PMCID: PMC2660200          DOI: 10.3132/dvdr.2006.031

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  14 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.

Authors: 
Journal:  Diabetes Care       Date:  2000-11       Impact factor: 19.112

3.  Aspirin therapy in diabetes.

Authors:  John A Colwell
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

4.  Enzymatic methods for quantification of lipoprotein lipids.

Authors:  G R Warnick
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

Authors:  G R Warnick; J Benderson; J J Albers
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

7.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis.

Authors:  R J Anderson; K E Freedland; R E Clouse; P J Lustman
Journal:  Diabetes Care       Date:  2001-06       Impact factor: 19.112

8.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

Authors:  Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski
Journal:  Control Clin Trials       Date:  2003-10

9.  Trends and correlates of class 3 obesity in the United States from 1990 through 2000.

Authors:  David S Freedman; Laura Kettel Khan; Mary K Serdula; Deborah A Galuska; William H Dietz
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

10.  Independent factors associated with major depressive disorder in a national sample of individuals with diabetes.

Authors:  Leonard E Egede; Deyi Zheng
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

View more
  96 in total

1.  Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study.

Authors:  L Maria Belalcazar; Christie M Ballantyne; Wei Lang; Steven M Haffner; Julia Rushing; Dawn C Schwenke; F Xavier Pi-Sunyer; Russell P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-21       Impact factor: 8.311

2.  Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.

Authors:  Alain G Bertoni; Lynne E Wagenknecht; Dalane W Kitzman; Santica M Marcovina; Julia T Rushing; Mark A Espeland
Journal:  Obesity (Silver Spring)       Date:  2011-09-29       Impact factor: 5.002

3.  Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial.

Authors:  Inga Peter; Jeanne M McCaffery; Alyson Kelley-Hedgepeth; Hakon Hakonarson; Steven Reis; Lynne E Wagenknecht; Alan S Kopin; Gondon S Huggins
Journal:  Obesity (Silver Spring)       Date:  2012-02-06       Impact factor: 5.002

4.  The Look AHEAD Trial: A Review and Discussion Of Its Outcomes.

Authors:  Xavier Pi-Sunyer
Journal:  Curr Nutr Rep       Date:  2014-12

5.  Weight Change 2 Years After Termination of the Intensive Lifestyle Intervention in the Look AHEAD Study.

Authors:  Ariana M Chao; Thomas A Wadden; Robert I Berkowitz; George Blackburn; Paula Bolin; Jeanne M Clark; Mace Coday; Jeffrey M Curtis; Linda M Delahanty; Gareth R Dutton; Mary Evans; Linda J Ewing; John P Foreyt; Linda J Gay; Edward W Gregg; Helen P Hazuda; James O Hill; Edward S Horton; Denise K Houston; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; William C Knowler; Anne Kure; Katherine L Michalski; Maria G Montez; Rebecca H Neiberg; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David Reboussin; Bruce Redmon; W Jack Rejeski; Helmut Steinburg; Martha Walker; Donald A Williamson; Rena R Wing; Holly Wyatt; Susan Z Yanovski; Ping Zhang
Journal:  Obesity (Silver Spring)       Date:  2020-05       Impact factor: 5.002

6.  Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions.

Authors:  Mark A Espeland; Jeffery Probstfield; Donald Hire; J Bruce Redmon; Gregory W Evans; Mace Coday; Cora E Lewis; Karen C Johnson; Sharon Wilmoth; Judy Bahnson; Michael F Dulin; Jennifer B Green; William C Knowler; Abbas Kitabchi; Anne L Murillo; Kwame Osei; Shakaib U Rehman; William C Cushman
Journal:  Am J Hypertens       Date:  2015-02-09       Impact factor: 2.689

7.  Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.

Authors:  Rena R Wing
Journal:  Arch Intern Med       Date:  2010-09-27

8.  Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial.

Authors:  Alvaro Alonso; Judy L Bahnson; Sarah A Gaussoin; Alain G Bertoni; Karen C Johnson; Cora E Lewis; Marion Vetter; Christos S Mantzoros; Robert W Jeffery; Elsayed Z Soliman
Journal:  Am Heart J       Date:  2015-07-26       Impact factor: 4.749

9.  Effects of a lifestyle intervention on REM sleep-related OSA severity in obese individuals with type 2 diabetes.

Authors:  Ari Shechter; Gary D Foster; Wei Lang; David M Reboussin; Marie-Pierre St-Onge; Gary Zammit; Anne B Newman; Richard P Millman; Thomas A Wadden; John M Jakicic; Elsa S Strotmeyer; Rena R Wing; F Xavier Pi-Sunyer; Samuel T Kuna
Journal:  J Sleep Res       Date:  2017-05-31       Impact factor: 3.981

Review 10.  Is it possible to reduce cardiovascular risk with glucose-lowering approaches?

Authors:  Hertzel C Gerstein
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.